MERCK to build a 1 billion dollar Dilayer factory to ensure local supply from Keytruda (MRK: NYSE)

Update: The company’s confirmation adds

Merck (New York:MrkIt has been cut off on a $ 1 billion facility Wilmengton, Dilayer, which has become the latest pharmaceutical company to enhance local investment with looming on the horizon targeted definitions of industry.

This is 470,000 square feet. Biology Center It will include a laboratory, manufacturing and warehouse